MedPath
NMPA Approval

Oseltamivir Phosphate Granules

国药准字H20249791

December 25, 2024

Drug Information

磷酸奥司他韦颗粒

颗粒剂

0.9g(按C₁₆H₂₈N₂O₄计)

化学药品

December 25, 2024

Company Information

Applicant Company

长沙高新开发区环联路7号

Manufacturing Company

湖南省长沙市高新区环联路7号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸奥司他韦颗粒 - NMPA 批准文号 | MedPath